Straumann, CH0012280076

Straumann stock gains 1.40 percent as Goldman lifts target to CHF 125.00

Published on 09/28/2026 at 10:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Straumann stock is supported by CHF 1,379.5 million in H1 sales and 7.8 percent organic growth. Goldman Sachs set a CHF 125.00 target on September 14, 2026.

Reinraum-Fertigung von Dentalimplantaten mit Ingenieuren an Präzisionsmaschinen
Straumann Holding AG (CH0012280076) betreibt moderne Reinraum-Fertigung für präzise Dentalimplantate in der Schweiz, Illustration mit AI erstellt.

Straumann stock (ISIN CH0012280076) was trading at CHF 98.84 on the SIX Swiss Exchange on September 28, 2026, up 1.40 percent from CHF 97.48. The move follows a September 14 upgrade from Goldman Sachs, which lifted its price target from CHF 106.00 to CHF 125.00.

Goldman raises the target

As Investing.com reported on September 14, 2026, Goldman Sachs upgraded Straumann from Buy from Neutral and raised the target to CHF 125.00 from CHF 106.00. The bank cited manufacturing and operating efficiencies, as well as improving Asia-Pacific demand, as potential drivers of fiscal 2027 earnings growth.

The new target is 26.46 percent above the September 28 price of CHF 98.84. That gap gives the analyst action a clear valuation dimension, while the share price remains 9.98 percent below its 52-week high of CHF 109.80.

H1 growth supports the case

Stock Sentinel reported that Straumann's H1 2026 sales reached CHF 1,379.5 million, representing 7.8 percent organic growth. Q2 organic growth accelerated to 8.5 percent, while core EBIT rose to CHF 354.8 million and the constant-currency core EBIT margin reached 26.9 percent, up 120 basis points.

Management reaffirmed its upgraded fiscal 2026 guidance for high-single-digit organic growth and 140 to 170 basis points of core EBIT-margin expansion at constant 2025 exchange rates. The figures make margin delivery the central operating test behind the higher analyst valuation.

Results date approaches

MarketScreener lists October 28, 2026 as Straumann's next earnings release date for third-quarter 2026. The upcoming report will test whether the H1 growth rate and the upgraded profitability outlook are carrying into the second half.

Stock remains below its high

Straumann was trading at CHF 98.84 on the SIX Swiss Exchange on September 28, 2026 at 10:39 a.m. CEST. The session range was CHF 97.26 to CHF 98.96, volume was 26,424 shares, and the 52-week range was CHF 73.02 to CHF 109.80.

Straumann stock key data

  • Company: Straumann Holding AG
  • ISIN: CH0012280076
  • Ticker: STMN
  • Trading venue: SIX Swiss Exchange
  • Price (as of September 28, 2026, 10:39 a.m. CEST): CHF 98.84
  • Market capitalization: CHF 15.8 billion (as of September 28, 2026)
  • 52-week range: CHF 73.02-109.80 (as of September 28, 2026)
  • Sector / Industry: Healthcare / Medical Equipment, Supplies & Distribution
  • Next earnings date: October 28, 2026

More news and analyses on Straumann stock

Disclaimer...

en | CH0012280076 | STRAUMANN | boerse | 70191814 | bgmi